ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

Shi, Xing-Yang; Zheng, Xiao-Min; Liu, Hui-Jie; Han, Xue; Zhang, Lei; Hu, Bei*; Li, Shan*广东省人民医院; 南方医科大学
Lipids in Health and Disease2023-12-4DOI: 10.1186/s12944-023-01976-z
7阅读
引用收藏
分享

摘要

BackgroundSteatosis and inflammation are the hallmarks of nonalcoholic steatohepatitis (NASH). Rotundic acid (RA) is among the key triterpenes of Ilicis Rotundae Cortex and has exhibited multipronged effects in terms of lowering the lipid content and alleviating inflammation. The study objective is to systematically evaluate the potential mechanisms through which RA affects the development and progression of NASH.MethodsTranscriptomic and proteomic analyses of primary hepatocytes isolated from the control, high-fat diet-induced NASH, and RA treatment groups were performed through Gene Ontology analysis and pathway enrichment. Hub genes were identified through network analysis. Integrative analysis revealed key RA-regulated pathways, which were verified by gene and protein expression studies and cell assays.ResultsHub genes were identified and enriched in the Toll-like receptor 4 (TLR4)/activator protein-1 (AP1) signaling pathway and glycolysis pathway. RA reversed glycolysis and attenuated the TLR4/AP1 pathway, thereby reducing lipid accumulation and inflammation. Additionally, lactate release in L-02 cells increased with NaAsO2-treated and significantly decreased with RA treatment, thus revealing that RA had a major impact on glycolysis.ConclusionsRA is effective in lowering the lipid content and reducing inflammation in mice with NASH by ameliorating glycolysis and TLR4/AP1 pathways, which contributes to the existing knowledge and potentially sheds light on the development of therapeutic interventions for patients with NASH.

学科与关键词

关键词
NASHRAGlycolysisTLR4/AP1ProteomicsTranscriptomics
相关
加载中…
  • Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota
    Liu, Hui-Jie; Cao, Sheng-Tian; Wen, Bao-Ying; Han, Xue; Li, Yong; Li, Shan; Li, Jing*; Zhang, Lei*International Immunopharmacology, 2021, 99: 108065.被引 10
  • Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/SCD1 signaling pathway and modulating gut microbiota (vol 99, 108065, 2021)
    Liu, Hui-Jie; Cao, Sheng-Tian; Wen, Bao-Ying; Han, Xue; Li, Yong; Li, Shan; Li, Jing*; Zhang, Lei*International Immunopharmacology, 2023, 125: 111084.
  • Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
    Du, Meng*; Wang, Xiaojing; Yuan, Lin; Liu, Bing; Mao, Xiaoxiang; Huang, Dandan; Yang, Liu; Huang, Kun; Zhang, Fengxiao; Wang, Yan; Luo, Xi; Wang, Cheng; Peng, Jiangtong; Liang, Minglu; Huang, Dan; Huang, KaiJournal of Hepatology, 2020, 73(6): 1333-1346.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Lipids in Health and Disease
发表日期
2023-12-04
卷期
第 22 卷, 第 1 期
页码
214
DOI
10.1186/s12944-023-01976-z
语言
ENGLISH
成果收录
SCIE
资助标注
National Key RD Projects

作者

  • S

    Shi, Xing-Yang (第一作者)

  • Z

    Zheng, Xiao-Min

查看全部 7 位作者收起作者
  • L

    Liu, Hui-Jie

  • H

    Han, Xue

  • Z

    Zhang, Lei

    guangdong inst drug control

  • H

    Hu, Bei (通讯)

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Shan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417